Literature DB >> 25700692

Validation of cold chain shipping environment for transport of allografts as part of a human tissue bank returns policy.

P Rooney1, M J Eagle2, J N Kearney3.   

Abstract

Human tissue is shipped to surgeons in the UK in either a freeze-dried or frozen state. To ensure quality and safety of the tissue, frozen tissue must be shipped in insulated containers such that tissue is maintained at an appropriate temperature. UK Blood Transfusion Service regulations state "Transportation systems must be validated to show maintenance of the required storage temperature" and also state that frozen, non-cryopreserved tissue "must be transported… at -20 °C or lower" (Guidelines for the Blood Transfusion Services in the United Kingdom, 8th Edn. 2013). To maintain an expiry date for frozen tissue longer than 6 months, the tissue must be maintained at a temperature of -40 °C or below. The objective of this study was to evaluate and validate the capability of a commercially available insulated polystyrene carton (XPL10), packed with dry ice, to maintain tissue temperature below -40 °C. Tissue temperature of a single frozen femoral head or a single frozen Achilles tendon, was recorded over a 4-day period at 37 °C, inside a XPL10 carton with dry ice as refrigerant. The data demonstrate that at 37 °C, the XPL10 carton with 9.5 kg of dry ice maintained femoral head and tendon tissue temperature below -55 °C for at least 48 h; tissue temperature did not rise above -40 °C until at least 70 h. Data also indicated that at a storage temperature lower than 37 °C, tissue temperature was maintained for longer periods.

Entities:  

Keywords:  Achilles tendon; Allograft; Container; Femoral head; Low temperature; Transport

Mesh:

Substances:

Year:  2015        PMID: 25700692     DOI: 10.1007/s10561-015-9502-0

Source DB:  PubMed          Journal:  Cell Tissue Bank        ISSN: 1389-9333            Impact factor:   1.522


  1 in total

1.  Room temperature shipment does not affect the biological activity of pluripotent stem cell-derived retinal organoids.

Authors:  Maria Georgiou; Valeria Chichagova; Gerrit Hilgen; Birthe Dorgau; Evelyne Sernagor; Lyle Armstrong; Majlinda Lako
Journal:  PLoS One       Date:  2020-06-01       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.